SARAH WUOLLET: Open Payments
NPI 1629401252 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$565 in 26 payments from 15 companies in 2025. Trend: 2023 $654 · 2024 $321 · 2025 $565
Food & beverage: $565
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $84 |
| Novartis Pharmaceuticals Corporation | 2 | $53 |
| GENZYME CORPORATION | 2 | $45 |
| Journey Medical Corporation | 2 | $43 |
| REVANCE THERAPEUTICS, INC. | 1 | $42 |
| UCB, Inc. | 2 | $41 |
| LEO Pharma Inc. | 2 | $38 |
| Amgen Inc. | 2 | $37 |
| Regeneron Healthcare Solutions, Inc. | 1 | $35 |
| Janssen Biotech, Inc. | 1 | $30 |
Products named: SKYRIZI, DUPIXENT, COSENTYX, DAXXIFY, Bimzelx, OTEZLA, TREMFYA, SOFDRA.
Industry payments across TX — which companies pay providers there.
